Weryński A, Waniewski J, Wang T, Anderstam B, Lindholm B, Bergström J
Institute of Biocybernetics and Biomedical Engineering, Warsaw, Poland.
Kidney Int. 2001 Jan;59(1):363-71. doi: 10.1046/j.1523-1755.2001.00499.x.
Dipeptide-based peritoneal dialysis solutions may have potential advantages compared with the glucose or amino acid-based solutions. Dipeptides may hydrolyze in the peritoneal cavity, generating constituent amino acids and thereby increasing the osmolality of the dialysate. Dipeptides can also be a valuable source of amino acids, which are poorly soluble in water, such as tyrosine.
Dwell studies in rats were performed during four hours with dipeptide solutions containing five dipeptides (Gly-His, Ala-Tyr, Thr-Leu, Ser-Phe, Val-Lys), 8, or 16 mmol/L of each dipeptide (low or high dipeptide group). Dwell studies were also performed with a 1.1% amino acid solution (Nutrineal(R)). The model of dipeptide hydrolysis (hydrolysis rate, KH), diffusive (rate constant, KBDD) and convective transport as well as transport of constituent amino acids consisted of mass balance equations, written for each dipeptide and amino acid.
Peritoneal volume with the amino acid solution decreased much faster than that with the high and low dipeptide solutions. KH for all dipeptides did not differ between the high and low dipeptide groups. In the low dipeptide group, KH was 0.004 +/- 0.004 mL/min (mean +/- SD) for Gly-His (the lowest) and 0.088 +/- 0.048 mL/min for Thr-Leu (the highest). KBDD was higher than KH for all dipeptides, the average being 0.2 +/- 0.05 mL/min.
Dipeptides are hydrolyzed in the peritoneal cavity, generating constituent amino acids. However, the hydrolysis rate appears to be several times lower than the dipeptide diffusive transport rate from dialysate to blood. Due to the higher molecular weight and intraperitoneal generation of amino acids, the dipeptide-based solutions provide more sustained ultrafiltration than the amino acid solution. The plasma concentration of amino acids at 60 minutes, in relation to the dose of amino acids delivered between 0 and 60 minutes, is considerably higher during the dwells with amino acid-based solution than during dwells with the dipeptide-based solutions.
与基于葡萄糖或氨基酸的腹膜透析液相比,基于二肽的腹膜透析液可能具有潜在优势。二肽可在腹膜腔内水解,生成组成氨基酸,从而增加透析液的渗透压。二肽也是氨基酸的宝贵来源,比如酪氨酸这种难溶于水的氨基酸。
用含有五种二肽(甘氨酰 - 组氨酸、丙氨酰 - 酪氨酸、苏氨酰 - 亮氨酸、丝氨酰 - 苯丙氨酸、缬氨酰 - 赖氨酸)的二肽溶液,以8或16 mmol/L的每种二肽浓度(低或高二肽组)在大鼠中进行4小时的驻留研究。还用1.1%的氨基酸溶液(Nutrineal®)进行了驻留研究。二肽水解模型(水解速率,KH)、扩散(速率常数,KBDD)和对流运输以及组成氨基酸的运输由针对每种二肽和氨基酸编写的质量平衡方程组成。
氨基酸溶液组的腹膜容积下降速度比高二肽溶液组和低二肽溶液组快得多。高二肽组和低二肽组中所有二肽的KH没有差异。在低二肽组中,甘氨酰 - 组氨酸(最低)的KH为0.004±0.004 mL/分钟(平均值±标准差),苏氨酰 - 亮氨酸(最高)的KH为0.088±0.048 mL/分钟。所有二肽的KBDD均高于KH,平均值为0.2±0.05 mL/分钟。
二肽在腹膜腔内水解,生成组成氨基酸。然而,水解速率似乎比二肽从透析液到血液的扩散运输速率低几倍。由于二肽分子量较高且在腹腔内生成氨基酸,基于二肽的溶液比氨基酸溶液提供更持续的超滤。与基于氨基酸的溶液驻留期间相比,在基于二肽的溶液驻留期间,60分钟时氨基酸的血浆浓度相对于0至60分钟期间输送的氨基酸剂量要高得多。